Actively Recruiting
Comparing Exercise Performance on Ambient Air Versus Nasal Low-Flow Liquid Oxygen Therapy in Patients with Exercise-Induced Desaturation from Pulmonary Vascular Disease
Led by Silvia Ulrich Somaini · Updated on 2026-09-09
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of liquid oxygen therapy on exercise performance in Swiss residents with pulmonary vascular diseases, including pulmonary arterial hypertension PAH and chronic thromboembolic pulmonary hypertension CTEPH. The study aims to compare the distance walked in six minutes 6-minute walk distance, 6MWD with and without supplemental liquid oxygen therapy. This trial uses a randomized crossover design to assess whether walking distance with oxygen therapy is inferior to walking distance on ambient air. Participants diagnosed with precapillary pulmonary hypertension groups 1 and 4 will perform two 6-minute walk tests one breathing ambient air and the other receiving liquid oxygen therapy at approximately 4 liters per minute through a nasal cannula. The oxygen therapy is provided during the test from a small oxygen tank at the University Hospital Zurich. Both tests follow clinical standards, and the order of treatments is randomized for each participant. During the study, participants will be assessed at the University Hospital Zurich where their walking distance, oxygen saturation SpO2, heart rate, blood pressure, and symptoms such as breathlessness and leg fatigue will be monitored at rest and after walking. The primary outcome is the difference in 6MWD between the oxygen therapy and ambient air conditions. Secondary outcomes include measurements of oxygen levels, heart rate, breathlessness scale, leg fatigue, and blood pressure during the tests. Participants must be stable on their current medication and will be followed until the study ends in December 2028.
CONDITIONS
Brief Title
Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)
Research Team
S
Silvia Ulrich, Prof. Dr. med.
M
Mona Lichtblau, PD. Dr. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here